Detalles de la búsqueda
1.
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Lancet Oncol
; 20(8): 1136-1147, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31221620
2.
Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
Int J Cancer
; 142(1): 165-175, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884470
3.
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation.
Proteomics
; 17(5)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28058811
4.
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Br J Cancer
; 114(6): 631-7, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26908327
5.
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.
Breast Cancer Res
; 17: 18, 2015 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25849327
6.
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).
Int J Cancer
; 137(7): 1729-38, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25820931
7.
Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: a national cohort study.
Int J Cancer
; 135(12): 2940-9, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24789418
8.
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Breast Cancer Res Treat
; 144(3): 577-82, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24567197
9.
Optimal age to start preventive measures in women with BRCA1/2 mutations or high familial breast cancer risk.
Int J Cancer
; 133(1): 156-63, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23292943
10.
Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile.
Psychooncology
; 22(3): 598-604, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22315183
11.
Preoperative breast MRI can reduce the rate of tumor-positive resection margins and reoperations in patients undergoing breast-conserving surgery.
AJR Am J Roentgenol
; 200(2): 304-10, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23345350
12.
Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial.
BMC Cancer
; 12: 440, 2012 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23031619
13.
The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer.
Psychooncology
; 21(2): 153-60, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22271535
14.
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Res
; 13(6): R110, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22053997
15.
Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk.
Breast
; 56: 1-6, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33515770
16.
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
JAMA Oncol
; 6(9): 1381-1389, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729887
17.
Breast cancer screening: evidence for false reassurance?
Int J Cancer
; 123(3): 680-6, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18484587
18.
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials.
Clin Cancer Res
; 13(24): 7357-62, 2007 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18094417
19.
Correction: MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.
Oncotarget
; 9(62): 32096, 2018 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30174799
20.
MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer.
Oncotarget
; 9(36): 24335-24346, 2018 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29849944